Source:http://linkedlifedata.com/resource/umls/id/C0018541
MSH: An antihyperlipoproteinemic agent and uricosuric agent.,NCI: A selective peroxisome proliferator-activated receptor gamma (PPAR-gamma) modulator with antilipidemic activity. Halofenate also decreases fasting plasma glucose in type 2 diabetic patients, but not normoglycemic subjects.